Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Regis HealthcareASX:REG -1.10%79 EV-to-EBIT is 4.84 as of Sep. 14, 2026, which is 67% below its 10-year median of 14.46. GuruFocus rates ASX:REG with a GF Score™ of 79/100 and a GF Value™ of A$9.01 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Regis Healthcare ranks better than 91.46% on this metric.
The historical rank and industry rank for Regis Healthcare's EV-to-EBIT or its related term are showing as below:
ASX:REG'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.84 Med: 14.46 Max: 54.5
Current: 4.84
During the past 12 years, the highest EV-to-EBIT of Regis Healthcare was 54.50. The lowest was 4.84. And the median was 14.46.
ASX:REG's EV-to-EBIT is ranked better than 91.46% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.06
vs ASX:REG: 4.84
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Regis Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was A$1,793 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regis Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was A$247 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare EV-to-EBIT Related Terms
Regis Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Regis Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Regis Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regis Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Regis Healthcare's EV-to-EBIT falls into.
Regis Healthcare's current Enterprise Value is A$1,194 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regis Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was A$247 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare (ASX:REG) has a EV-to-EBIT of 4.84 as of Sep. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Regis Healthcare and its competitors. This is 67% below median its historical median of 14.46. Over the past decade, Regis Healthcare's EV-to-EBIT has ranged from 4.84 to 54.50. According to the industry distribution chart, Regis Healthcare ranks #41 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 8.5%.
Is Regis Healthcare's EV-to-EBIT too high?
Regis Healthcare's current EV-to-EBIT of 4.84 is 67% below median its 10-year median of 14.46. Over the past 10 years, this metric has ranged from a low of 4.84 to a high of 54.50. The Healthcare Providers & Services industry median EV-to-EBIT is 15.06. Regis Healthcare's value of 4.84 is 67.9% below this industry median. Based on the distribution chart, Regis Healthcare ranks #41 out of 480 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Regis Healthcare has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #41 out of 480 companies for EV-to-EBIT. This places Regis Healthcare in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.06. Regis Healthcare's value of 4.84 is 67.9% below this benchmark. Historically, Regis Healthcare's own EV-to-EBIT has ranged from 4.84 to 54.50 over the past decade. While the company's 10-year median is 14.46 vs. the industry median of 15.06, Regis Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.06, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regis Healthcare's current EV-to-EBIT of 4.84 is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Regis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current EV-to-EBIT is 4.84, which is 67% below median its own 10-year median of 14.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$9.01, compared to a current price of A$4.51 — trading 49.9% below its estimated fair value. The current EV-to-EBIT is 4.84, which is 67% below median its 10-year median of 14.46 and 67.9% below the Healthcare Providers & Services industry median of 15.06. Regis Healthcare's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current EV-to-EBIT is 4.84 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regis Healthcare (ASX:REG) Overvalued in 2026?
Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued.
The current stock price of A$4.51 is trading 49.9% below its estimated GF Value™ of A$9.01.
GuruFocus considers Regis Healthcare to be Possible Value Trap.
Key valuation signals for ASX:REG:
EV-to-EBIT: 4.84 (67% below median its 10-year median of 14.46)
GF Value™: A$9.01 vs. price of A$4.51 (49.9% below fair value)
Industry Position: 67.9% below the Healthcare Providers & Services median (#41 of 480)
No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
79GF Score
Get the complete analysis for ASX:REG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:REG has been successfully added to your 
